Src kinases as therapeutic targets for cancer

Src family kinases have been extensively studied and found to be central mediators in multiple signaling pathways that are important in oncogenesis. Preclinical studies have shown that SFK inhibitors can suppress tumor growth and metastases. The authors of this Review discuss the potential use of these agents to target cancer in humans.